Use this url to cite publication: https://hdl.handle.net/20.500.12512/90696
A Dizziness handicap index in peripheral vertigo – Lithuanian experience
Type of publication
Konferencijų tezės nerecenzuojamame leidinyje / Conference theses in non-peer-reviewed publication (T2)
Title
A Dizziness handicap index in peripheral vertigo – Lithuanian experience
Virgilijus Uloza, Ingrida Uloziene, Inga Urbonaviciute
Publisher (trusted)
International Federation of Otorhinolaryngological Society
Date Issued
| Date Issued |
|---|
2013-06-01 |
Extent
1 skelb., no. FP61-09.
Is part of
IFOS - 20th World Congress the International Federationof Oto-Rhino-Laryngological Societies [elektroninis išteklius - CD] Innovation and Integration in ORL-HNS : June 1-5, 2013, Seoul. Korea : Abstract CD / International Federation of Otorhino-laryngological Society. Korean Society of Otorhinolaryngology-Head and Neck Surgery. Seoul : IFOS, 2013.
Version
Originalus / Original
Series/Report no.
Abstract. Free Paper (FP).
Abstract. Free Paper (FP).
Field of Science
Abstract
Introduction. The study OSVaLD (A Three-Month Observational Study in Patients Suffering from Recurrent Peripheral Vestibular Vertigo to Assess the Effect of Betahistine 48 mg/day on Quality of Life and Dizziness Symptoms) was conducted in 13 countries. Our aim was to extract Lithuanian country specific data from the study and evaluate the Dizziness Handicap Index (DHI) score changes obtained clevieng the study. Material and methods. Betahistine 48 mg/day (24 mg b.i.d. or 16 mg t.i.d.), was prescribed either as monotherapy or as adjunctive therapy. [...].
Type of document
type::text::conference output::conference proceedings::conference paper
Other Identifier(s)
(LSMU ALMA)990000821250107106
Coverage Spatial
Pietų Korėja / Korea Republic of (KR)
Language
Anglų / English (en)